カテゴリ： IMARC, 世界, 医療/バイオ

世界の呼吸器診断市場予測2023年-2028年

■ 英語タイトル：Respiratory Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

調査会社IMARC社が発行したリサーチレポート（データ管理コード：IMARC23JLY227）■ 発行会社/調査会社：IMARC
■ 商品コード：IMARC23JLY227
■ 発行日：2023年7月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：145
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※IMARC社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の呼吸器診断市場予測2023年-2028年]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

IMARC社は、2022年75億ドルであった世界の呼吸器診断市場規模が、予測期間中（2023年～2028年）年平均7.65％成長し、2028年には117億ドルに達すると予測しています。当調査資料では、呼吸器診断の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品・サービスタイプ別（機器＆サービス、アッセイ＆試薬、サービス＆ソフトウェア）分析、検査タイプ別（機械的試験、閉塞性睡眠時無呼吸症候群（OSA）診断検査、画像検査、従来型診断検査、その他）分析、疾患別（結核、喘息、慢性閉塞性肺疾患（COPD）、肺がん、その他）分析、エンドユーザー別（病院、診療所、リファレンス＆臨床検査室、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東/アフリカ、中南米）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。なお、当市場の主要企業には、Philips Healthcare、Abbott Laboratories、Biomerieux、Becton Dickinson、Thermo Fisher Scientific Inc.、Alere Inc.、Seegene Inc.、3M、Bio-Rad Laboratories、SDI Diagnostics and COSMEDなどが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の呼吸器診断市場規模：製品・サービスタイプ別
- 機器＆サービスの市場規模
- アッセイ＆試薬の市場規模
- サービス＆ソフトウェアの市場規模
・世界の呼吸器診断市場規模：検査タイプ別
- 機械的試験の市場規模
- 閉塞性睡眠時無呼吸症候群（OSA）診断検査の市場規模
- 画像検査の市場規模
- 従来型診断検査の市場規模
- その他検査の市場規模
・世界の呼吸器診断市場規模：疾患別
- 結核における市場規模
- 喘息における市場規模
- 慢性閉塞性肺疾患（COPD）における市場規模
- 肺がんにおける市場規模
- その他疾患における市場規模
・世界の呼吸器診断市場規模：エンドユーザー別
- 病院における市場規模
- 診療所における市場規模
- リファレンス＆臨床検査室における市場規模
- その他エンドユーザーにおける市場規模
・世界の呼吸器診断市場規模：地域別
- 北米の呼吸器診断市場規模
- ヨーロッパの呼吸器診断市場規模
- アジア太平洋の呼吸器診断市場規模
- 中東/アフリカの呼吸器診断市場規模
- 中南米の呼吸器診断市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況

Market Overview:

The global respiratory diagnostics market size reached US$ 7.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2028, exhibiting a growth rate (CAGR) of 7.65% during 2023-2028.

Respiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.

The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth. Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory diagnostics market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product and service type, test type, disease and end-user.

Breakup by Product and Service Type:
Instruments and Services
Assays and Reagents
Services and Software

Breakup by Test Type:
Mechanical Tests
Obstructive Sleep Apnoea (OSA) Diagnostic Tests
Imaging Tests
Traditional Diagnostic Tests
Molecular Diagnostic Tests
Others

Breakup by Disease:
Tuberculosis
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Lung Cancer
Others

Breakup by End-User:
Hospitals
Clinics
Reference and Clinical Laboratories
Others

Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics and COSMED.

Key Questions Answered in This Report:
How has the global respiratory diagnostics market performed so far and how will it perform in the coming years?
What are the key regional markets in the global respiratory diagnostics industry?
What has been the impact of COVID-19 on the global respiratory diagnostics industry?
What is the breakup of the market based on the product and service type?
What is the breakup of the market based on the test type?
What is the breakup of the market based on the disease?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the global respiratory diagnostics industry?
What are the key driving factors and challenges in the global respiratory diagnostics industry?
What is the structure of the global respiratory diagnostics industry and who are the key players?
What is the degree of competition in the global respiratory diagnostics industry?

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Respiratory Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product and Service Type
5.5 Market Breakup by Test Type
5.6 Market Breakup by Disease
5.7 Market Breakup by End-User
5.8 Market Breakup by Region
5.9 Market Forecast
6 Market Breakup by Product and Service Type
6.1 Instruments and Services
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Assays and Reagents
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services and Software
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Test Type
7.1 Mechanical Tests
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Imaging Tests
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Traditional Diagnostic Tests
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Molecular Diagnostic Tests
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Disease
8.1 Tuberculosis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Asthma
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Chronic Obstructive Pulmonary Disease (COPD)
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Lung Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Reference and Clinical Laboratories
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Philips Healthcare
14.3.2 Abbott Laboratories
14.3.3 Biomérieux
14.3.4 Becton Dickinson
14.3.5 Thermo Fisher Scientific Inc.
14.3.6 Alere Inc.
14.3.7 Seegene Inc.
14.3.8 3M
14.3.9 Bio-Rad Laboratories Inc.
14.3.10 SDI Diagnostics
14.3.11 COSMED

Figure 1: Global: Respiratory Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Respiratory Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Respiratory Diagnostics Market: Breakup by Product and Service Type (in %), 2022
Figure 4: Global: Respiratory Diagnostics Market: Breakup by Test Type (in %), 2022
Figure 5: Global: Respiratory Diagnostics Market: Breakup by Disease (in %), 2022
Figure 6: Global: Respiratory Diagnostics Market: Breakup by End User (in %), 2022
Figure 7: Global: Respiratory Diagnostics Market: Breakup by Region (in %), 2022
Figure 8: Global: Respiratory Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Respiratory Diagnostics Industry: SWOT Analysis
Figure 10: Global: Respiratory Diagnostics Industry: Value Chain Analysis
Figure 11: Global: Respiratory Diagnostics Industry: Porter’s Five Forces Analysis
Figure 12: Global: Respiratory Diagnostics (Instruments and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Respiratory Diagnostics (Instruments and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Respiratory Diagnostics (Assays and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Respiratory Diagnostics (Assays and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Respiratory Diagnostics (Services and Software) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Respiratory Diagnostics (Services and Software) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Respiratory Diagnostics (Mechanical Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Respiratory Diagnostics (Mechanical Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Respiratory Diagnostics (Imaging Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Respiratory Diagnostics (Imaging Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Respiratory Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Respiratory Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Respiratory Diagnostics (Tuberculosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Respiratory Diagnostics (Tuberculosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Respiratory Diagnostics (Asthma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Respiratory Diagnostics (Asthma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Respiratory Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Respiratory Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Respiratory Diagnostics (Other Disease Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Respiratory Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Respiratory Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Respiratory Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Respiratory Diagnostics (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Respiratory Diagnostics (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Global: Respiratory Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Global: Respiratory Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: North America: Respiratory Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: North America: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Respiratory Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Asia Pacific: Respiratory Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Asia Pacific: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Middle East and Africa: Respiratory Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Middle East and Africa: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Latin America: Respiratory Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Latin America: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の等温核酸増幅技術市場予測2023年-2028年
  • 世界の呼吸ケア機器市場予測2023年-2028年
  • 世界のレジオネラ菌検査市場予測2023年-2028年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IMARC23JLY227 )"世界の呼吸器診断市場予測2023年-2028年" (英文：Respiratory Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)はIMARC社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。